Ming‐hsi Huang - Infectious Diseases

Author Information

Ming-Hsi Huang is a distinguished researcher affiliated with the National Institute of Infectious Diseases and Vaccinology at the National Health Research Institutes in Miaoli, Taiwan. In addition to this primary affiliation, Huang is connected with the Graduate Institute of Biomedical Sciences at China Medical University in Taichung and the Graduate Institute of Medicine at Kaohsiung Medical University in Kaohsiung, Taiwan. Huang's research is focused on infectious diseases, with a strong emphasis on vaccine development and adjuvant technologies.

Research Contributions

Ming-Hsi Huang has made significant contributions to the field of infectious diseases, particularly in the development and enhancement of vaccines. Huang's work includes exploring innovative adjuvant systems to improve vaccine efficacy, such as the use of PELC/CpG adjuvants for influenza vaccines. The research also delves into the synthesis and application of polymeric materials for drug delivery and the engineering of bioresorbable polymers, showcasing a multidisciplinary approach that spans immunology, materials science, and pharmaceutical sciences.

Aliases

Ming-Hsi Huang is also recognized in academic circles under the aliases Minglu Huang and Ming‑hsi Huang. These variations may appear in publications and citations related to Huang's work.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1218
H-index	18
Total Paper Count	55

Publications:

Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine

DOI: 10.3390/vaccines8020240

Year: 2020

Elaboration of Charged Poly(Lactic-co-Glycolic Acid) Microparticles for Effective Release of Tranexamic Acid

DOI: 10.3390/polym12040808

Year: 2020

Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses

DOI: 10.3390/vaccines8040710

Year: 2020

Impact of antigen-adjuvant associations on antigen uptake and antigen-specific humoral immunity in mice following intramuscular injection.

DOI: 10.1016/j.biopha.2019.109373

Year: 2019

Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development

DOI: 10.1016/j.vaccine.2019.02.040

Year: 2019

One-pot amphiphilic engineering of bioresorbable polymers for constructing colloidal vesicles and prolonging protein delivery

DOI: 10.1038/s41428-019-0267-3

Year: 2019

Synthesis and thermal investigation of phosphate-functionalized acrylic materials

DOI: 10.1038/s41428-018-0086-y

Year: 2018

Towards Boosting Power by Encapsulating Tranexamic Acid into Emulsified Particles

DOI: 10.1155/2018/8101540

Year: 2018

Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.

DOI: 10.1021/acs.molpharmaceut.7b00800

Year: 2018

Polysorbasome: A Colloidal Vesicle Contoured by Polymeric Bioresorbable Amphiphiles as an Immunogenic Depot for Vaccine Delivery.

DOI: 10.1021/acsami.8b03044

Year: 2018

What is Resource Allocation in Infectious Diseases?

How is Malaria Diagnosed and Treated?

What are Aedes Mosquitoes?

What Does a Regular Health Check-Up Entail?

How Do X-rays Assist in Diagnosing Infections?

What is Schistosomiasis?

How are Structural Proteins Studied?

What Happens After the Throat Swab is Collected?

Are condoms effective against all STIs?

What are the Symptoms of Cervical Cancer?

Partnered Content Networks

Relevant Topics